Skip to main content
. 2022 Jul 14;108(23):1873–1880. doi: 10.1136/heartjnl-2022-321196

Figure 4.

Figure 4

Summary figure showing the study design and the efficacy and safety outcomes in events/100 patient-years of EAST-AFNET4 eligible participants in the UK Biobank receiving either early rhythm control or usual care in the overall cohort and a propensity-score matched analysis. The HRs and the 95% CIs are presented in brackets. HR <1 favours early rhythm control. AF, atrial fibrillation; EAST-AFNET4, Early Treatment of Atrial Fibrillation for Stroke Prevention Trial.